arrow_back Back to App

Federal Funding Ban on Sex-Trait Altering Treatments for Minors.

This law prohibits the use of federal funds to pay for, promote, or support medical treatments that alter sex traits in individuals under 18. It establishes new, strengthened rights for parents regarding consent for such treatments and creates a long window for individuals who received these treatments as minors to sue medical providers for harm. Medical institutions and schools risk losing federal funding if they violate these rules.
Key points
Federal money cannot be used to fund, promote, or support sex-trait altering treatments (including puberty blockers and hormones) for individuals under 18.
Parents gain the right to decline such treatments, and states violating these parental rights (e.g., by separating a child from a parent) risk losing specific federal funds (like Medicaid).
Individuals harmed by these treatments received as minors have 30 years after reaching adulthood to file a lawsuit against medical providers or institutions, potentially receiving treble damages.
Healthcare providers are protected from penalties or discrimination if they refuse to participate in or refer for these treatments based on conscience.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_2387
Sponsor: Rep. Onder, Robert [R-MO-3]
Process start date: 2025-03-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

No Harm Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_2387.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-03-26.

What are the main provisions?

Key points include:

  • Federal money cannot be used to fund, promote, or support sex-trait altering treatments (including puberty blockers and hormones) for individuals under 18.
  • Parents gain the right to decline such treatments, and states violating these parental rights (e.g., by separating a child from a parent) risk losing specific federal funds (like Medicaid).
  • Individuals harmed by these treatments received as minors have 30 years after reaching adulthood to file a lawsuit against medical providers or institutions, potentially receiving treble damages.
  • Healthcare providers are protected from penalties or discrimination if they refuse to participate in or refer for these treatments based on conscience.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Onder, Robert [R-MO-3].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Family Courts and Law